sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Vegf Vegfr Inhibitor Drugs Market Scope And Analysis

  • Report Code : TIPRE00014917
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse de la dynamique et de la portée du marché des médicaments inhibiteurs du VEGF/VEGFR d'ici 2025-2031

Buy Now

VEGF/VEGFR Inhibitor Drugs Market Report VEGF/VEGFR Inhibitor Drugs Market Size and Share VEGF/VEGFR Inhibitor Drugs Market Scope and Analysis

VEGF/VEGFR Inhibitor Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 7.90%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • inhibiteurs de la tyrosine kinase
  • anticorps monoclonaux
  • autres
By Application
  • Oncologie
  • Ophtalmologie
  • Autres
By Géographie
  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer
  • Novartis AG
  • GlaxoSmithKline plc
  • Sanofi
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Bayer AG